Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968500 · ClinicalTrials.gov registry record
Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer
A clinical trial of Parents Who Have Lost a Child to Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 160
- Enrollment target
- 2
- Study locations
NCT00968500: Active study of Parents Who Have Lost a Child to Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00968500 is a study of Parents Who Have Lost a Child to Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 160 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00968500, a study of Parents Who Have Lost a Child to Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to understand the experiences and needs of parents who have lost a child to cancer. This will aid us in developing an intervention that may help parents cope with their loss.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires/Interviews
Study Locations (2)
Maryland
- NCI Clinical Center - Bethesda
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2009-08 |
| Est. Completion | 2027-06-02 |
What the registry record for NCT00968500 still lists
NCT00968500 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Parents Who Have Lost a Child to Cancer appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires/Interviews is the first listed.
NCT00968500 reports a single indexed study location in Maryland, New York.
Frequently Asked Questions
What is clinical trial NCT00968500 about?
NCT00968500 is a clinical study titled "Understanding the Psychosocial Needs of Parents Who Have Lost a Child to Cancer". The purpose of this study is to understand the experiences and needs of parents who have lost a child to cancer. This will aid us in developing an intervention that may help parents cope with their loss.
What is the current status of trial NCT00968500?
This trial is currently active not recruiting. The enrollment target is 160 participants. The study started on 2009-08. Estimated completion is 2027-06-02.
What conditions does trial NCT00968500 study?
This clinical trial studies the following conditions: Parents Who Have Lost a Child to Cancer.
What interventions are being tested in trial NCT00968500?
The interventions under investigation include: Questionnaires/Interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT00968500?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00968500 being conducted?
This trial has 2 study locations across Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia